Alessia Belgi

Dr. Alessia Belgi

ARC Training Centre for Green Chemistry in Manufacturing, School of Chemistry, Monash University, Clayton, VIC 3800, Australia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FSFazel Shabanpoor
Fazel Shabanpoor
MHMohammad Akhter Hossain
Mohammad Akhter Hossain
PRPhilip J. Ryan
Philip J. Ryan
ABAlessia Belgi
Alessia Belgi
SLSharon Layfield
Sharon Layfield
JWJohn D. Wade
John D. Wade

17 June 2013 in ACS Chemical Biology
Verified
Journal Article
Closed access
BLBianca J. van Lierop
Bianca J. van Lierop
Samuel RobinsonSamuel Robinson
Samuel Robinson
SKShiva N. Kompella
Shiva N. Kompella
ABAlessia Belgi
Alessia Belgi
JMJeffrey McArthur
Jeffrey McArthur
ARAndrea Jane Robinson
Andrea Jane Robinson

1 December 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SCSandeep Chhabra
Sandeep Chhabra
ABAlessia Belgi
Alessia Belgi
PBPeter Bartels
Peter Bartels
BLBianca J. van Lierop
Bianca J. van Lierop
Samuel RobinsonSamuel Robinson
Samuel Robinson
Raymond NortonRaymond Norton
Raymond Norton

6 August 2020 in Toxins
Verified
Journal Article
Open access
PDF file
AKAdam Kennedy
Adam Kennedy
ABAlessia Belgi
Alessia Belgi
BHBenjamin W. Husselbee
Benjamin W. Husselbee
DSDavid Spanswick
David Spanswick
Raymond NortonRaymond Norton
Raymond Norton
ARAndrea Jane Robinson
Andrea Jane Robinson
Several analgesic α-conotoxins have been isolated from marine cone snails. Structural modification of native peptides has provided potent and selective analogues for two of its known biological targets—nicotinic acetylcholine and γ-aminobutyric acid (GABA) G protein-coupled (GABAB) receptors. Both of these molecular targets are implicated in pain pathways. Despite their small size, an incomplete understanding of the structure-activity relationship of α-conotoxins at each of these targets has hampered the development of therapeutic leads. This review scrutinises the N-terminal domain of the α-conotoxin family of peptides, a region defined by an invariant disulfide bridge, a turn-inducing proline residue and multiple polar sidechain residues, and focusses on structural features that provide analgesia through inhibition of high-voltage-activated Ca2+ channels. Elucidating the bioactive conformation of this region of these peptides may hold the key to discovering potent drugs for the unmet management of debilitating chronic pain associated with a wide range of medical conditions.

1 April 2017 in Toxicon
Verified
Journal Article
Closed access
SDStephen B. Drane
Stephen B. Drane
Samuel RobinsonSamuel Robinson
Samuel Robinson
CMChris Macraild
Chris Macraild
SCSandeep Chhabra
Sandeep Chhabra
BCBalasubramanyam Chittoor
Balasubramanyam Chittoor
Raymond NortonRaymond Norton
Raymond Norton

12 May 2023 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
ATAmy Lea Thomson
Amy Lea Thomson
EGEllen C. Gleeson
Ellen C. Gleeson
ABAlessia Belgi
Alessia Belgi
WJW. Roy Jackson
W. Roy Jackson
EIEkaterina I. Izgorodina
Ekaterina I. Izgorodina
ARAndrea Jane Robinson
Andrea Jane Robinson
Ru-Alkylidene catalysed olefin metathesis generates metabolically stable cystine bridge peptidomimetics with defined geometry. Deleterious coordinative bonding to the catalyst by sulfur-containing functionality found in cysteine and methionine residues can be negated by in situ and reversible oxidation of thiol and thioether functionality, as disulfides and S-oxides respectively, to facilitate high yielding ring-closing and cross metathesis of bioorthogonally protected peptides.